237 related articles for article (PubMed ID: 33176774)
1. Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting.
Campbell PT; Geard N; Hogan AB
BMC Med; 2020 Nov; 18(1):319. PubMed ID: 33176774
[TBL] [Abstract][Full Text] [Related]
2. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
[TBL] [Abstract][Full Text] [Related]
4. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
Baral R; Li X; Willem L; Antillon M; Vilajeliu A; Jit M; Beutels P; Pecenka C
Vaccine; 2020 Jul; 38(33):5139-5147. PubMed ID: 32586761
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.
Kinyanjui TM; House TA; Kiti MC; Cane PA; Nokes DJ; Medley GF
PLoS One; 2015; 10(9):e0138018. PubMed ID: 26390032
[TBL] [Abstract][Full Text] [Related]
6. Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy.
Mapindra MP; Mahindra MP; McNamara P; Semple MG; Clark H; Madsen J
Neonatology; 2024; 121(3):271-282. PubMed ID: 38286126
[TBL] [Abstract][Full Text] [Related]
7. Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households.
Brand SP; Munywoki P; Walumbe D; Keeling MJ; Nokes DJ
Elife; 2020 Mar; 9():. PubMed ID: 32216871
[TBL] [Abstract][Full Text] [Related]
8. Potential impact of a maternal vaccine for RSV: A mathematical modelling study.
Hogan AB; Campbell PT; Blyth CC; Lim FJ; Fathima P; Davis S; Moore HC; Glass K
Vaccine; 2017 Oct; 35(45):6172-6179. PubMed ID: 28967522
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus seasonality and its implications on prevention strategies.
Janet S; Broad J; Snape MD
Hum Vaccin Immunother; 2018 Jan; 14(1):234-244. PubMed ID: 29194014
[TBL] [Abstract][Full Text] [Related]
10. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
Madhi SA; Polack FP; Piedra PA; Munoz FM; Trenholme AA; Simões EAF; Swamy GK; Agrawal S; Ahmed K; August A; Baqui AH; Calvert A; Chen J; Cho I; Cotton MF; Cutland CL; Englund JA; Fix A; Gonik B; Hammitt L; Heath PT; de Jesus JN; Jones CE; Khalil A; Kimberlin DW; Libster R; Llapur CJ; Lucero M; Pérez Marc G; Marshall HS; Masenya MS; Martinón-Torres F; Meece JK; Nolan TM; Osman A; Perrett KP; Plested JS; Richmond PC; Snape MD; Shakib JH; Shinde V; Stoney T; Thomas DN; Tita AT; Varner MW; Vatish M; Vrbicky K; Wen J; Zaman K; Zar HJ; Glenn GM; Fries LF;
N Engl J Med; 2020 Jul; 383(5):426-439. PubMed ID: 32726529
[TBL] [Abstract][Full Text] [Related]
11. Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
Riddell CA; Bhat N; Bont LJ; Dupont WD; Feikin DR; Fell DB; Gebretsadik T; Hartert TV; Hutcheon JA; Karron RA; Nair H; Reiner RC; Shi T; Sly PD; Stein RT; Wu P; Zar HJ; Ortiz JR;
Vaccine; 2018 Dec; 36(52):8100-8109. PubMed ID: 30473186
[TBL] [Abstract][Full Text] [Related]
12. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.
Kurai D; Mizukami A; Preckler V; Verelst F; Molnar D; Matsuki T; Ho Y; Igarashi A
Expert Rev Vaccines; 2024; 23(1):303-311. PubMed ID: 38426479
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine.
Régnier SA
Vaccine; 2013 Sep; 31(40):4347-54. PubMed ID: 23896421
[TBL] [Abstract][Full Text] [Related]
14. Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants.
Giannini F; Hogan AB; Sarna M; Glass K; Moore HC
BMC Infect Dis; 2024 May; 24(1):510. PubMed ID: 38773455
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
Scheltema NM; Kavelaars XM; Thorburn K; Hennus MP; van Woensel JB; van der Ent CK; Borghans JAM; Bont LJ; Drylewicz J
Vaccine; 2018 Jul; 36(31):4693-4700. PubMed ID: 29941327
[TBL] [Abstract][Full Text] [Related]
16. Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
Prasad N; Read JM; Jewell C; Waite B; Trenholme AA; Huang QS; Grant CC; Newbern EC; Hogan AB
Vaccine; 2021 Jul; 39(31):4383-4390. PubMed ID: 34147296
[TBL] [Abstract][Full Text] [Related]
17. Model-based estimates of transmission of respiratory syncytial virus within households.
Kombe IK; Munywoki PK; Baguelin M; Nokes DJ; Medley GF
Epidemics; 2019 Jun; 27():1-11. PubMed ID: 30591267
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
Munoz FM
Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.
Koltai M; Moyes J; Nyawanda B; Nyiro J; Munywoki PK; Tempia S; Li X; Antillon M; Bilcke J; Flasche S; Beutels P; Nokes DJ; Cohen C; Jit M
BMC Med; 2023 Mar; 21(1):120. PubMed ID: 37004062
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study.
Li Y; Hodgson D; Wang X; Atkins KE; Feikin DR; Nair H
Lancet Infect Dis; 2021 Sep; 21(9):1303-1312. PubMed ID: 33965062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
